BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35193825)

  • 21. Effect of umbilical cord mesenchymal stromal cells on motor functions of identical twins with cerebral palsy: pilot study on the correlation of efficacy and hereditary factors.
    Wang X; Hu H; Hua R; Yang J; Zheng P; Niu X; Cheng H; Dai G; Liu X; Zhang Z; An Y
    Cytotherapy; 2015 Feb; 17(2):224-31. PubMed ID: 25593078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies.
    Paton MCB; Wall DA; Elwood N; Chiang KY; Cowie G; Novak I; Finch-Edmondson M
    Cytotherapy; 2022 Jan; 24(1):2-9. PubMed ID: 34384698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy outcomes after intranasal administration of neural stem cells in cerebral palsy: a randomized phase 1/2 controlled trial.
    Lv Z; Li Y; Wang Y; Cong F; Li X; Cui W; Han C; Wei Y; Hong X; Liu Y; Ma L; Jiao Y; Zhang C; Li H; Jin M; Wang L; Ni S; Liu J
    Stem Cell Res Ther; 2023 Feb; 14(1):23. PubMed ID: 36759901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise Review: Stem Cell Interventions for People With Cerebral Palsy: Systematic Review With Meta-Analysis.
    Novak I; Walker K; Hunt RW; Wallace EM; Fahey M; Badawi N
    Stem Cells Transl Med; 2016 Aug; 5(8):1014-25. PubMed ID: 27245364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of cord blood cell therapy with erythropoietin for children with CP: a 2 × 2 factorial randomized placebo-controlled trial.
    Min K; Suh MR; Cho KH; Park W; Kang MS; Jang SJ; Kim SH; Rhie S; Choi JI; Kim HJ; Cha KY; Kim M
    Stem Cell Res Ther; 2020 Nov; 11(1):509. PubMed ID: 33246489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroregenerative potential of intravenous G-CSF and autologous peripheral blood stem cells in children with cerebral palsy: a randomized, double-blind, cross-over study.
    Rah WJ; Lee YH; Moon JH; Jun HJ; Kang HR; Koh H; Eom HJ; Lee JY; Lee YJ; Kim JY; Choi YY; Park K; Kim MJ; Kim SH
    J Transl Med; 2017 Jan; 15(1):16. PubMed ID: 28109298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preschool HABIT-ILE: study protocol for a randomised controlled trial to determine efficacy of intensive rehabilitation compared with usual care to improve motor skills of children, aged 2-5 years, with bilateral cerebral palsy.
    Sakzewski L; Reedman S; McLeod K; Thorley M; Burgess A; Trost S; Ahmadi M; Rowell D; Chatfield M; Bleyenheuft Y; Boyd RN
    BMJ Open; 2021 Mar; 11(3):e041542. PubMed ID: 33653745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gross motor function in children with spastic Cerebral Palsy and Cerebral Visual Impairment: A comparison between outcomes of the original and the Cerebral Visual Impairment adapted Gross Motor Function Measure-88 (GMFM-88-CVI).
    Salavati M; Rameckers EA; Waninge A; Krijnen WP; Steenbergen B; van der Schans CP
    Res Dev Disabil; 2017 Jan; 60():269-276. PubMed ID: 27771178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonate use in children with cerebral palsy.
    Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of Immune Responses in the Efficacy of Cord Blood Cell Therapy for Cerebral Palsy.
    Kang M; Min K; Jang J; Kim SC; Kang MS; Jang SJ; Lee JY; Kim SH; Kim MK; An SA; Kim M
    Stem Cells Dev; 2015 Oct; 24(19):2259-68. PubMed ID: 25977995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrathecal injection of CD133-positive enriched bone marrow progenitor cells in children with cerebral palsy: feasibility and safety.
    Zali A; Arab L; Ashrafi F; Mardpour S; Niknejhadi M; Hedayati-Asl AA; Halimi-Asl A; Ommi D; Hosseini SE; Baharvand H; Aghdami N
    Cytotherapy; 2015 Feb; 17(2):232-41. PubMed ID: 25593079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy.
    Liu X; Fu X; Dai G; Wang X; Zhang Z; Cheng H; Zheng P; An Y
    J Transl Med; 2017 Feb; 15(1):48. PubMed ID: 28235424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hippotherapy on gross motor function and functional performance of children with cerebral palsy.
    Park ES; Rha DW; Shin JS; Kim S; Jung S
    Yonsei Med J; 2014 Nov; 55(6):1736-42. PubMed ID: 25323914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years.
    Beckung E; Carlsson G; Carlsdotter S; Uvebrant P
    Dev Med Child Neurol; 2007 Oct; 49(10):751-6. PubMed ID: 17880644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.
    Goussetis E; Peristeri I; Kitra V; Papassavas AC; Theodosaki M; Petrakou E; Spiropoulos A; Paisiou A; Soldatou A; Stavropoulos-Giokas C; Graphakos S
    Blood Cells Mol Dis; 2011 Feb; 46(2):177-81. PubMed ID: 21095146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of side-alternating vibration therapy on mobility and health outcomes in young children with mild to moderate cerebral palsy: design and rationale for the randomized controlled study.
    Adaikina A; Hofman PL; Gusso S
    BMC Pediatr; 2020 Nov; 20(1):508. PubMed ID: 33153439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of the modified Gross Motor Function Measure-88 (GMFM-88) for children with both Spastic Cerebral Palsy and Cerebral Visual Impairment: A preliminary study.
    Salavati M; Krijnen WP; Rameckers EA; Looijestijn PL; Maathuis CG; van der Schans CP; Steenbergen B
    Res Dev Disabil; 2015; 45-46():32-48. PubMed ID: 26210850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study protocol for Running for health (Run4Health CP): a multicentre, assessor-blinded randomised controlled trial of 12 weeks of two times weekly Frame Running training versus usual care to improve cardiovascular health risk factors in children and youth with cerebral palsy.
    Reedman SE; Sakzewski L; McNamara L; Sherrington C; Beckman E; West K; Trost SG; Thomas R; Chatfield MD; Dutia I; Gennen A; Dodds B; Cotton Z; Boyd RN
    BMJ Open; 2022 Apr; 12(4):e057668. PubMed ID: 35487751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action.
    Jiao Y; Li XY; Liu J
    Cell Transplant; 2019 May; 28(5):497-509. PubMed ID: 30384766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy.
    Chen G; Wang Y; Xu Z; Fang F; Xu R; Wang Y; Hu X; Fan L; Liu H
    J Transl Med; 2013 Jan; 11():21. PubMed ID: 23351389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.